INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 198 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 1.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $602,000 | -30.1% | 12,560 | -8.1% | 0.01% | -42.9% |
| Q1 2020 | $861,000 | -42.3% | 13,660 | +8.8% | 0.01% | -6.7% |
| Q4 2019 | $1,491,000 | +78.8% | 12,560 | 0.0% | 0.02% | +66.7% |
| Q3 2019 | $834,000 | -18.6% | 12,560 | -2.3% | 0.01% | -18.2% |
| Q2 2019 | $1,024,000 | +509.5% | 12,860 | +757.3% | 0.01% | +450.0% |
| Q1 2019 | $168,000 | +479.3% | 1,500 | +200.0% | 0.00% | – |
| Q4 2017 | $29,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2017 | $29,000 | -52.5% | 500 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $61,000 | +7.0% | 500 | 0.0% | 0.00% | – |
| Q1 2017 | $57,000 | +5600.0% | 500 | +24900.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 2 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 2 | -50.0% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 4 | +100.0% | 0.00% | – |
| Q4 2015 | $1,000 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |